Your browser doesn't support javascript.
loading
Novel PD-1 inhibitor prolgolimab: expanding non-resectable/metastatic melanoma therapy choice.
Tjulandin, Sergey; Demidov, Lev; Moiseyenko, Vladimir; Protsenko, Svetlana; Semiglazova, Tatiana; Odintsova, Svetlana; Zukov, Ruslan; Lazarev, Sergey; Makarova, Yuliya; Nechaeva, Marina; Sakaeva, Dina; Andreev, Aleksey; Tarasova, Anna; Fadeyeva, Natalya; Shustova, Mariia; Kuryshev, Ivan.
Affiliation
  • Tjulandin S; N. N. Blokhin National Cancer Research Medical Center of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.
  • Demidov L; N. N. Blokhin National Cancer Research Medical Center of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.
  • Moiseyenko V; Saint Petersburg Clinical Research and Practice Center for Specialized Medical Care (Oncology), Saint Petersburg, Russia.
  • Protsenko S; N. N. Petrov National Cancer Research Medical Center, Saint Petersburg, Russia.
  • Semiglazova T; N. N. Petrov National Cancer Research Medical Center, Saint Petersburg, Russia.
  • Odintsova S; JSC «Sovremennye Meditsinskie Tekhnologii¼, Saint Petersburg, Russia.
  • Zukov R; A. I. Kryzhanovsky Krasnoyarsk Regional Clinical Oncology Center, Krasnoyarsk, Russia.
  • Lazarev S; Altai Krai Oncology Center, Barnaul, Russia.
  • Makarova Y; Clinical Oncology Center No 1 of the Ministry of Healthcare of Krasnodar Krai, Krasnodar, Russia.
  • Nechaeva M; Arkhangelsk Regional Clinical Oncology Center, Arkhangelsk, Russia.
  • Sakaeva D; Republican Clinical Oncology Center of the Ministry of Healthcare of the Republic of Bashkortostan, Ufa, Russia.
  • Andreev A; Medical Center of the Federal Medical and Biological Agency, Novosibirsk, Russia.
  • Tarasova A; Samara Regional Clinical Oncology Center, Samara, Russia.
  • Fadeyeva N; Chelyabinsk Regional Center of Oncology and Nuclear Medicine, Chelyabinsk, Russia.
  • Shustova M; JSC BIOCAD, Saint Petersburg, Russia. Electronic address: shustova@biocad.ru.
  • Kuryshev I; JSC BIOCAD, Saint Petersburg, Russia.
Eur J Cancer ; 149: 222-232, 2021 05.
Article in En | MEDLINE | ID: mdl-33872982
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Skin Neoplasms / Programmed Cell Death 1 Receptor / Immune Checkpoint Inhibitors / Melanoma Type of study: Clinical_trials / Guideline Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia / Europa Language: En Journal: Eur J Cancer Year: 2021 Type: Article Affiliation country: RUSSIA
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Skin Neoplasms / Programmed Cell Death 1 Receptor / Immune Checkpoint Inhibitors / Melanoma Type of study: Clinical_trials / Guideline Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia / Europa Language: En Journal: Eur J Cancer Year: 2021 Type: Article Affiliation country: RUSSIA